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Human liver mRNA was prepared from a patient homozygous for hi-antrtrypsin defictency (PiZZ) and 
from a normal subject (PiMM). Both hver RNAs were microinJected into Xenopus oocytes and 
cur-antitrypsin identified by immunopreciprtation. The normal M variant of cYt-antitrypsm is synthesised 
and secreted by Xenopus oocytes, the abnormal Z protein is not secreted and an mtracellular form 
accumulates m the oocytes. In the presence of tumcamycm an unglycosylated form of M al-antitrypsm 
appears in the incubation medium but no corresponding unglycosylated version of the Z protein 1s 
secreted. 
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1. INTRODUCTION 
err-Antitrypsin is one of the most important pro- 
teinase inhibitors found in human plasma [ 11. The 
glycoprotein is synthesised in the liver, but acts 
principally in the lung to prevent proteolytic 
damage to the pulmonary alveoli [ 1,2]. In view of 
this protective function it is not surprising that 
chronic pulmonary disease often arises in patients 
with inborn deficiency of al-antitrypsin [3]. What 
is surprising is that homozygotes for the genetic 
variant of cur-antitrypsin, known as PiZ, frequent- 
ly sustain damage to the liver as well as the lung 
[4]. Indeed, the endoplasmic reticulum of affected 
livers contains large deposits of ur-antitrypsin [5,6] 
and this has led to the suggestion that 
cyr-antitrypsin deficiency of the PiZZ type arises 
from a failure in secretion. The accumulations of 
intracellular inhibitor which result may give rise to 
a susceptibility to further liver damage [ 11. DNA 
sequence studies [7] have shown that a single point 
mutation of the normal PiM gene gives rise to the 
PiZ genotype. The mutation causes a glutamic acid 
to lysine substitutron at position 342 in the 
Xenopus oocyte 
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polypeptide chain but how this alteration prevents 
the protein from being secreted is unknown. 
Messenger RNA for PiZ al-antitrypsin translates 
as efficiently as the normal message in a cell-free 
translation system [8]. Furthermore, the mutant 
protein is correctly sequestered within dog pan- 
creas microsomes and core glycosylated [9], sug- 
gesting that the block in secretion occurs at a later 
stage in the secretory pathway. 
We have chosen to study this problem using 
Xenopus oocytes as a model secretory system. 
Xenopus oocytes are capable of translating a wide 
variety of exogenous mRNAs [lo]. Foreign 
secretory proteins are modified post-trans- 
lationally and exported from the oocyte 111,121 
which makes rt a suitable surrogate system for our 
purposes. 
2. MATERIALS AND METHODS 
Liver samples were obtained by biopsy (nor- 
mals) or as a result of liver transplantation (PiZZ 
homozygote). Liver samples were cut into small 
pieces and rapidly frozen and stored in liquid 
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nitrogen. Normal tissue was obtained from several 
donors and all were phenotyped as PiM. The PiZZ 
donor was a 7-year-old girl undergoing liver 
transplantation. Microscopic examination of the 
liver from the deficient patient revealed in- 
tracellular inclusions of cYi-antitrypsin. Oligo(dT) 
cellulose was from BRL Laboratories (Science 
Park, Cambridge); L-[%]methionine (> 800 
Ci - mmol-‘) and 14C-labelled marker proteins were 
from Amersham International (Amersham, 
Bucks.); antihuman cur-antitrypsin raised in rabbits 
was from DAK0 (Copenhagen). All other reagents 
were analytical grade and were supplied by Sigma 
(Poole, Dorset). 
Liver poly(A+) RNA was prepared by a 
modification of the method in [13]. Frozen liver 
samples (2 g) were pulverised in a percussion mor- 
tar before homogenisation using a Potter Teflon 
and glass homogeniser. This homogenisation pro- 
cedure is particularly important when dealing with 
PiZZ liver, which tends to be very fibrous. 
Poly(A+) RNA was separated using oligo(dT) 
cellulose affinity chromatography. Two g of liver 
yielded 50-80 pg poly(A+) RNA. Preparation and 
use of the cell-free translation system were as in 
[ 141. Oocytes of Xenopus hews were maintained 
in Barths’ saline and microinjected as in [12,15]. 
Oocytes were microinjected with mRNA with or 
without tunicamycin at 40 pg. ml-‘. Injected 
oocytes were cultured in unlabelled Barth’s saline 
for 24 h at 21°C (-2pg*ml-’ tunicamycin). 
Unhealthy oocytes were discarded and the remain- 
ing oocytes were cultured in Barth’s saline contain- 
ing 0.8 mCi.ml-’ [3’S]methionine for 7 h. In the 
pulse chase experiment oocytes were removed from 
the labelled medium and incubated for a further 
24 h in medium containing 10 mM methionine. 
Oocytes were homogenised according to [15]. 
Oocyte extracts and incubation media were im- 
munoprecipitated with anti-cui-antitrypsin as in 
[16]. Polyacrylamide gels (1090, w/v) and subse- 
quent fluorography were as in [ 141. Two- 
dimensional gel electrophoresis was according to 
u71. 
3. RESULTS AND DISCUSSION 
We prepared poly(A+) RNA from the livers of 
normal and PiZZ patients. Batches of oocytes were 
then microinjected with either PiMM or PiZZ 
mRNA and incubated in the presence of medium 
containing [35S]methionine. Fig.1 (tracks 1 and 2) 
shows a control immunoprecipitation of non- 
injected oocytes using anti-cur-antitrypsin. The 
bands seen represent non-specific binding to the 
antibody-protein A-Sepharose complex and were 
not removed by ‘clearing’ immunoprecipitations 
or extensive washing of the complex. When 
oocytes injected with liver RNA were similarly 
treated additional bands, specific for al-anti- 
trypsin, were clearly visible (tracks 3-6). A 58-kDa 
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Ftg.1. The synthesis and secretron of cyr-antrtrypsm m 
oocytes. Oocytes were microinjected with liver poly(A+) 
RNA and mcubated m medium containing t3’S]meth- 
ronine as described in section 2. Antibody precrpitates 
from incubatron media and oocyte extracts were examin- 
ed by SDS-polyacrylamide gel electrophoresrs. I, m- 
cubatron medium; 0, oocyte extract. Arrows 1 and 2 
denote the 58kDa and 54-kDa forms of err-antrtrypsm 
referred to m the text. iWr values shown on the left of the 
figure were derived from the comigration of r4C-labelled 
markers, carbonic anhydrase (30000), ovalbumin 
(46000) and bovine serum albumin (69000). 
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protein was found in the incubation medium from 
oocytes injected with PiMM mRNA (track 3). This 
secreted form was usually absent if oocytes were 
injected with PiZZ mRNA (track 5) although in 
some experiments a small amount of PiZ al-anti- 
trypsin is secreted into the medium (see fig.3, track 
7). A 54-kDa protein appeared in oocytes injected 
with normal or mutant mRNA (tracks 4 and 6). 
Evidently, little PiZ cY1-antitrypsin is secreted by 
oocytes but the intracellular precursor appears in 
all oocytes injected with liver mRNA. The dif- 
ference between intracellular precursors of PiM 
and PiZ inhibitor is clearly resolved in the pulse 
chase experiment showh in fig.2. 
Fig.2 displays the result of an experiment when 
oocytes were labelled for 7 h then ‘chased’ by 
transfer to media containing 10 mM methionine 
- RNA +:zlYM +FEz 
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Fig.2. Disposition of cur-antrtrypsin from pulse-labelled 
oocytes. Oocytes were microinjected with liver poly(A+) 
RNA and pulse-labelled as described in section 2. 
Antibody precipitates were examined by SDS- 
polyacrylamide gel electrophoresis as before. I, 
incubation medium; 0, oocyte extract. Arrows 1 and 2 
denote 58-kDa and 54-kDa forms of cur-antitrypsin as 
before. Tracks A and B show cur-antitrypsm synthesrsed 
in a cell-free system after addition of PiMM RNA, wrth 
(B) or without (A) membranes. * Migration of 
unlabelled marker al-antrtrypsm from human serum. 
for a further 24 h. The intracellular PiM 
cui-antitrypsin disappeared with concurrent ap- 
pearance of the secreted protein in the medium 
(tracks 3 and 4). The PiZ precursor emained in the 
oocyte during the chase period and little export oc- 
curred (tracks 5 and 6) over this period. There ap- 
peared to be no intracellular degradation of 
unsecreted PiZ protein over the chase period. The 
intracellular form of cYi-antitrypsin migrated 
slightly faster than the membrane-processed, cell- 
free translation product (track 8). This may in- 
dicate different degrees of core glycosylation in 
oocytes and canine microsomes or some further 
sugar modification to the oocyte protein. The total 
export of PIM cui-antitrypsin seen in fig.2 is not 
always observed. In other experiments we have 
seen only a partial clearing of intracellular precur- 
sor over the chase period. These quantitative dif- 
ferences are probably due to batch to batch varia- 
tion in the oocytes. On no occasion was PiZ 
cri-antitrypsin efficiently secreted into the medium. 
These results suggest that the treatment of normal 
and abnormal variants of cYi-antitrypsin in the 
oocyte accurately reflects events in the hepatocytes 
of normal and PiZZ individuals. 
The contribution of attached oligosaccharide 
units toward glycoprotein secretion is somewhat 
variable (review [18]). ai-Antitrypsin is a complex 
glycoprotein with 3 asparagine-linked oligosac- 
charide chains per molecule and in the case of the 
PiZ variant the possibility arises that the attached 
core sugars may play some part in the block in 
secretion from the liver. We have investigated the 
effect of glycosylation on the fate of normal and 
mutant cwi-antitrypsin by incubating injected 
oocytes with tunicamycin, an inhibitor of core 
glycosylation. 
In the presence of tunicamycin a new 45kDa 
protein is secreted from oocytes microinjected with 
normal mRNA (fig.3, track 5). This represents 
secretion of unglycosylated PiM cui-antitrypsin 
after cleavage of the signal peptide and is 
analogous to findings from experiments using rat 
hepatocytes incubated with tunicamycin [19,20]. 
Although the unglycosylated protein was found in- 
tracellularly in oocytes injected with either normal 
or mutant mRNA (tracks 6 and 8), there was no 
corresponding export of an unglycosylated form of 
PiZ ai-antitrypsin (track 7). The cri-antitrypsin 
which accumulates in the liver of patients 
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Fig.3. The effect of tumcamycin on protem secretion i  
oocytes. Oocytes were microinjected with mRNA from 
human liver or hen oviduct and cultured in the presence 
or absence of tunicamycin. Antibody precipitates of 
incubation media and oocyte extracts were prepared 
using either anti-ovalbumin or ant&l-antitrypsin and 
examined as before. I, incubation medium; 0, oocyte 
extract. Arrows 1,2 and 3 denote 58-kDa, 54-kDa and 
4%kDa forms of ~~-antit~psin referred to in the text. 
Ov and Ov’ , glycosylated and un~ycosylat~ forms of 
ovalbumin. 
homozygous for the Z variant is at least partly core 
glycosylated and has a high mannose content 1211. 
It is possible that decreased solubility of the in- 
tracellular abnormal protein is the cause of the 
failure to secrete. However, we can say that the ad- 
dition of core sugars plays little or no part in this 
decreased solubility since tu~~ycin did not 
alleviate the block in export from oocytes. 
The tunicamycin treatment was not completely 
effective as judged by the presence of the 54-kDa 
intracellular band in tracks 6 and 8. However it is 
interesting to note that, in contrast to the in- 
tracellular situation, in the media the glycosylated 
and not the unglycosylated form of ~~-antitr~sin 
predominates (track 5). We conclude therefore 
that the fully glycosylated molecule is exported 
from the oocyte far more rapidly than the 
unglycosylated molecule. This effect of glycosyla- 
tion on secretion rate did not extend to another 
protein, chick ovalbumin. As shown in [ll] the 
secretion rate of ovalbumin is not affected by 
glycosylation (cf. fig.3, tracks 1 and 2,3 and 4). At 
present we cannot explain the intense band of 
about 66-kDa seen in fig.3, track 5. This band was 
seen in other experiments but its intensity relative 
to al-antitrypsin was much lower. This band was 
only seen in media surrounding oocytes injected 
with PiMM RNA. 
Our results show that the failure to process cor- 
rectly and secrete PiZ al-antitrypsin is not con- 
fined to the hepatocyte. Also, we show that the ab- 
normal glycosylation in itself is not the cause of the 
secretory block since unglycosylated Pi2 protein is 
not secreted. One might wonder why an aberrant 
protein is not correctly translocated once it has 
entered the secretory pathway. A similar situation 
has been reported in studies on a mutant h2 light 
chain [22]. A one-residue substitution blocks secre- 
tion of the globulin and it accumulates in the 
myeloma cell. This h2 light chain is also not 
secreted in monomer form from Xenopus oocytes 
after mRNA microinjection [23]. In the case of 
cul-antitrypsin a simple answer may be that the mu- 
tant inhibitor has a reduced solubility and ag- 
gregates in the endoplasmic reticulum. However, 
there remain two other interesting possibi~ties. 
One, that the mutation in the protein causes its 
diversion to some cellular compartment of the liver 
not on the secretory pathway and the second that 
the aberrant protein fails to bind to a receptor in 
the endoplasmic reticulum which is required for 
correct transport. These suggestions are open to 
experimental investigation. 
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